Related Experiment Video

Updated: May 3, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

7.6K

Oncogenic microRNAs in the genesis of leukemia and lymphoma

Yanyan Pan, Mei Meng, Gaochuan Zhang

  • 1Cyrus Tang Hematology Center, Soochow University, 199 Ren Ai Road, Suzhou Industrial Park, Suzhou 215123, China. quanshengzhou@yahoo.com.

Current Pharmaceutical Design
|February 1, 2014
PubMed

Insights

Oncogenic microRNAs (miRNAs) drive leukemia and lymphoma development by affecting cell growth and survival. These miRNAs show potential as diagnostic markers and therapeutic targets for blood cancers.

Area of Science:

  • Molecular Biology
  • Oncology
  • Hematology

Background:

  • MicroRNAs (miRNAs) are increasingly recognized for their roles in cancer development.
  • Aberrant miRNA expression is implicated in the pathogenesis of hematological malignancies like leukemia and lymphoma.

Purpose of the Study:

  • To review the role of oncogenic miRNAs in the initiation and progression of leukemia and lymphoma.
  • To explore the potential of miRNAs as diagnostic, prognostic, and therapeutic targets in these cancers.

Main Methods:

  • Literature review of studies investigating miRNA expression and function in leukemia and lymphoma.
  • Analysis of specific oncogenic miRNAs (e.g., miR-155, miR-17-92) and their impact on cellular processes.

Main Results:

  • Specific miRNAs (e.g., miR-155, miR-17-92, miR-21, miR-125b) promote leukemogenesis by affecting stem cell populations, proliferation, differentiation, and apoptosis.
  • These oncogenic miRNAs are also implicated in lymphomagenesis, altering gene expression and signaling pathways in hematopoietic cells.
  • miR-155 and miR-17-92 significantly impact gene expression and signaling, driving both leukemogenesis and lymphomagenesis.

Conclusions:

  • MicroRNAs play a critical role in the genesis of leukemia and lymphoma.
  • Oncogenic miRNAs represent promising diagnostic and prognostic biomarkers for patients.
  • Targeting oncogenic miRNAs offers a potential strategy for novel anti-leukemia and anti-lymphoma drug development.

More Related Videos

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.5K
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.2K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
MicroRNAs01:22

MicroRNAs

9.8K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.6K